Login / Signup
Editorial: intravenous to subcutaneous vedolizumab-switch without glitch! Authors' reply.
Viktoria Bergqvist
Johanna Holmgren
Daniel Klintman
Jan Marsal
Published in:
Alimentary pharmacology & therapeutics (2022)
Keyphrases
</>
ulcerative colitis
patients with inflammatory bowel disease
high dose
low dose